{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2022,3,29]],"date-time":"2022-03-29T07:51:25Z","timestamp":1648540285176},"reference-count":41,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2015,2,5]],"date-time":"2015-02-05T00:00:00Z","timestamp":1423094400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Bioinformatics"],"published-print":{"date-parts":[[2015,12]]},"DOI":"10.1186\/s12859-015-0452-0","type":"journal-article","created":{"date-parts":[[2015,2,4]],"date-time":"2015-02-04T08:44:20Z","timestamp":1423039460000},"update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Data-intensive analysis of HIV mutations"],"prefix":"10.1186","volume":"16","author":[{"given":"Mina Cintho","family":"Ozahata","sequence":"first","affiliation":[]},{"given":"Ester Cerdeira","family":"Sabino","sequence":"additional","affiliation":[]},{"given":"Ricardo Sobhie","family":"Diaz","sequence":"additional","affiliation":[]},{"suffix":"Jr","given":"Roberto","family":"M Cesar-","sequence":"additional","affiliation":[]},{"given":"Jo\u00e3o Eduardo","family":"Ferreira","sequence":"additional","affiliation":[]}],"member":"297","published-online":{"date-parts":[[2015,2,5]]},"reference":[{"key":"452_CR1","first-page":"65","volume":"8","author":"RF Schinazi","year":"2000","unstructured":"Schinazi RF, Larder B, Mellors JW. Mutations in retroviral genes associated with drug resistance:pages = 2000-2001 update. Int\u2019l Antiviral News. 2000; 8:65\u201392.","journal-title":"Int\u2019l Antiviral News"},{"key":"452_CR2","unstructured":"Brazilian algorithm. \n                    http:\/\/forrest.ime.usp.br:3001\/resistencia\n                    \n                  . www.aids.gov.br."},{"key":"452_CR3","volume-title":"Proc. 15th Nat\u2019l Conf. Artificial Intelligence 10th Conf. Innovative Applications of Artificial Intelligence, Menlo Park Calif","author":"RH Lathrop","year":"1998","unstructured":"Lathrop RH. Knowledge-based avoidance of drug-resistant hiv mutants In: Press A, editor. Proc. 15th Nat\u2019l Conf. Artificial Intelligence 10th Conf. Innovative Applications of Artificial Intelligence, Menlo Park Calif. Madison, WI: AAAI Press: 1998. p. 1071\u20138."},{"issue":"11","key":"452_CR4","doi-asserted-by":"publisher","first-page":"1290","DOI":"10.1038\/81407","volume":"6","author":"R Shafer","year":"2000","unstructured":"Shafer R, Jung DR, Betts BJ. Human immunodeficiency virus type 1 reverse transcriptase and protease mutation search engine for queries. Nat Med. 2000; 6(11):1290\u20132.","journal-title":"Nat Med."},{"issue":"1","key":"452_CR5","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1186\/1758-2652-14-45","volume":"14","author":"JCC Fernandez","year":"2011","unstructured":"DCF, S, MC, S, R, B, Fernandez JCC, SE, LA, I, Diaz R. The brazilian network for hiv-1 genotyping (renageno) external quality control assurance program (eqa). J Int AIDS Soc. 2011; 14(1):45.","journal-title":"J Int AIDS Soc."},{"key":"452_CR6","first-page":"285","volume":"3721","author":"T Sing","year":"2005","unstructured":"Sing T, Svicher T, Beerenwinkel N, Ceccherini-Silberstein F, Daumer M, Kaiser R, et al. Characterization of novel hiv drug resistance mutations using clustering, multidimensional scaling and svm-based feature ranking. In Knowledge Discovery in Databases: PKDD. 2005; 3721:285\u201396.","journal-title":"In Knowledge Discovery in Databases: PKDD"},{"issue":"10","key":"452_CR7","doi-asserted-by":"publisher","first-page":"1243","DOI":"10.1093\/bioinformatics\/btn110","volume":"24","author":"Y Liu","year":"2008","unstructured":"Liu Y, Eyal E, Bahar I. Analysis of correlated mutations in hiv-1 protease using spectral clustering. Bioinformatics. 2008; 24(10):1243\u201350.","journal-title":"Bioinformatics"},{"issue":"7","key":"452_CR8","doi-asserted-by":"publisher","first-page":"1477","DOI":"10.1093\/jac\/dkq140","volume":"65","author":"EC Reuman","year":"2010","unstructured":"Reuman EC, Rhee S, Holmes SP, Shafer RW. Constrained patterns of covariation and clustering of hiv-1 non-nucleoside reverse transcriptase inhibitor resistance mutations. J Antimicrob Chemother. 2010; 65(7):1477\u201385.","journal-title":"J Antimicrob Chemother"},{"key":"452_CR9","doi-asserted-by":"publisher","first-page":"3122","DOI":"10.1128\/AAC.48.8.3122-3126.2004","volume":"48","author":"SY Rhee","year":"2004","unstructured":"Rhee SY, Liu T, Ravela J, J, GM, Shafer RW. Distribution of human immunodeficiency virus type 1 protease and reverse transcriptase mutation patterns in 4,183 persons undergoing genotypic resistance testing. Antimicrob Agents Chemother. 2004; 48:3122\u20136.","journal-title":"Antimicrob Agents Chemother."},{"issue":"8","key":"452_CR10","doi-asserted-by":"publisher","first-page":"4836","DOI":"10.1128\/JVI.77.8.4836-4847.2003","volume":"77","author":"TD Wu","year":"2003","unstructured":"Wu TD, Schiffer CA, Gonzales MJ, Taylor J, Kantor R, Chou R, et al. Mutation patterns and structural correlates in human immunodeficiency virus type 1 protease following different protease inhibitor treatments. J Virol. 2003; 77(8):4836\u201347.","journal-title":"J Virol"},{"key":"452_CR11","doi-asserted-by":"publisher","first-page":"791","DOI":"10.1097\/00002030-200304110-00003","volume":"17","author":"MJ Gonzales","year":"2003","unstructured":"Gonzales MJ, Wu TD, Taylor J, Belitskaya I, Kantor R, Israelski D, et al. Extended spectrum of hiv-1 reverse transcriptase mutations in patients receiving multiple nucleoside analog inhibitors. AIDS. 2003; 17:791\u20139.","journal-title":"AIDS"},{"key":"452_CR12","doi-asserted-by":"publisher","first-page":"536","DOI":"10.1016\/S0042-6822(03)00484-7","volume":"17","author":"NG Hoffman","year":"2003","unstructured":"Hoffman NG, Schiffer CA, Swanstrom R. Covariation of amino acid positions in hiv-1 protease. Virology. 2003; 17:536\u201348.","journal-title":"Virology"},{"issue":"1","key":"452_CR13","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1186\/1471-2334-9-111","volume":"9","author":"C Alteri","year":"2009","unstructured":"Alteri C, Svicher V, Gori C, D\u2019Arrigo R, Ciccozzi M, Ceccherini-Silberstein F, et al. Characterization of the patterns of drug-resistance mutations in newly diagnosed hiv-1 infected patients na\u00efve to the antiretroviral drugs. BMC Infectious Diseases. 2009; 9(1):111.","journal-title":"BMC Infectious Diseases"},{"key":"452_CR14","doi-asserted-by":"publisher","first-page":"477","DOI":"10.1186\/1471-2105-12-477","volume":"12","author":"KM Doherty","year":"2011","unstructured":"Doherty KM, Nakka P, King BM, Rhee S, Holmes SP, Shafer RW, et al. A multifaceted analysis of hiv-1 protease multidrug resistance phenotypes. BMC Bioinf. 2011; 12:477.","journal-title":"BMC Bioinf."},{"issue":"16","key":"452_CR15","doi-asserted-by":"publisher","first-page":"1946","DOI":"10.1093\/bioinformatics\/btt331","volume":"29","author":"D Heider","year":"2013","unstructured":"Heider D, Senge R, Cheng W, H\u00fcllermeier E. Multilabel classification for exploiting cross-resistance information in hiv-1 drug resistance prediction. Bioinformatics. 2013; 29(16):1946\u201352.","journal-title":"Bioinformatics"},{"issue":"12","key":"452_CR16","doi-asserted-by":"crossref","first-page":"4099","DOI":"10.1128\/JCM.37.12.4099-4106.1999","volume":"37","author":"N Yahi","year":"1999","unstructured":"Yahi N, Tamalet C, Tourres C, Tivoli N, Ariasi F, Volot F, et al. Mutation patterns of the reverse transcriptase and protease genes in human immunodeficiency virus type 1-infected patients undergoing combination therapy: survey of 787 sequences. J Clin Microbiol. 1999; 37(12):4099\u2013106.","journal-title":"J Clin Microbiol."},{"key":"452_CR17","doi-asserted-by":"publisher","first-page":"507","DOI":"10.1007\/BF02253366","volume":"7","author":"N Yahi","year":"2000","unstructured":"Yahi N, Tamalet C, Tourres C, Tivoli N, Fantini J. Mutation l210w of hiv-1 reverse transcriptase in patients receiving combination therapy, incidence, association with other mutations, and effects on the structure of mutated reverse transcriptase. J Biomed Sci. 2000; 7:507\u201313.","journal-title":"J Biomed Sci."},{"key":"452_CR18","doi-asserted-by":"publisher","first-page":"904","DOI":"10.1086\/315329","volume":"181","author":"GJ Hanna","year":"2000","unstructured":"Hanna GJ, Johnson VA, Kuritzkes DR, Richman DD, Brown AJ, Savara AV, et al. Pattern of resistance mutations selected by treatment of human immunodeficiency virus type 1 infection with zidovudine, didanosine and nevirapine. J Infectious Diseases. 2000; 181:904\u201311.","journal-title":"J Infectious Diseases"},{"key":"452_CR19","doi-asserted-by":"publisher","first-page":"162","DOI":"10.1002\/jmv.10550","volume":"72","author":"AG Marcelin","year":"2004","unstructured":"Marcelin AG, Delaugerre C, Wirden M, Viegas P, Simon A, Katlama C, et al. Thymidine analogue reverse transcriptase inhibitors resistance mutations profiles and association to other nucleoside reverse transcriptase inhibitors resistance mutations observed in the context of virological failure. J Med Virol. 2004; 72:162\u20135.","journal-title":"J Med Virol."},{"key":"452_CR20","doi-asserted-by":"publisher","first-page":"862","DOI":"10.1086\/381676","volume":"189","author":"P Flandre","year":"2004","unstructured":"Flandre P, Descamps D, Joly V, Meiffredy V, Tamalet C, Izopet J, et al. A survival method to estimate the time to occurrence of mutations: an application to thymidine analogue mutations in hiv-1-infected patients. J Infectious Diseases. 2004; 189:862\u201370.","journal-title":"J Infectious Diseases"},{"key":"452_CR21","doi-asserted-by":"publisher","first-page":"3478","DOI":"10.1128\/AAC.47.11.3478-3484.2003","volume":"47","author":"K Wolf","year":"2003","unstructured":"Wolf K, Walter H, Beerenwinkel N, Keulen W, Kaiser R, Hoffmann D, et al. Tenofovir resistance and resensitization. Antimicrob Agents Chemother. 2003; 47:3478\u201384.","journal-title":"Antimicrob Agents Chemother."},{"issue":"9","key":"452_CR22","doi-asserted-by":"publisher","first-page":"1","DOI":"10.2165\/11633630-000000000-00000","volume":"72","author":"MW Tang","year":"2012","unstructured":"Tang MW, Shafer RW. Hiv-1 antiretroviral resistance: scientific principles and clinical applications. Drugs. 2012; 72(9):1\u201325.","journal-title":"Drugs"},{"issue":"3","key":"452_CR23","doi-asserted-by":"publisher","first-page":"382","DOI":"10.1016\/j.meegid.2006.09.004","volume":"7","author":"K Deforche","year":"2007","unstructured":"Deforche K, Camacho R, Grossman Z, Silander T, Soares MA, Moreau Y, et al. Bayesian network analysis of resistance pathways against hiv-1 protease inhibitors. Infection Genet Evol. 2007; 7(3):382\u201390.","journal-title":"Infection Genet Evol."},{"issue":"1","key":"452_CR24","doi-asserted-by":"publisher","first-page":"298","DOI":"10.1093\/nar\/gkg100","volume":"31","author":"S Rhee","year":"2003","unstructured":"Rhee S, Gonzales MJ, Kantor R, Betts BJ, Ravela J, Shafer RW. Human immunodeficiency virus reverse transcriptase and protease sequence database. Nucleic Acids Res. 2003; 31(1):298\u2013303.","journal-title":"Nucleic Acids Res."},{"issue":"4","key":"452_CR25","first-page":"211","volume":"2","author":"RRK Shafer","year":"2000","unstructured":"Shafer RRK, Gonzales MJ. The genetic basis of hiv-1 resistance to reverse transcriptase and protease inhibitors. AIDS Rev. 2000; 2(4):211\u201328.","journal-title":"AIDS Rev."},{"issue":"4","key":"452_CR26","first-page":"156","volume":"19","author":"A Johnson","year":"2011","unstructured":"Johnson A, Calvez V, G\u00fcnthard H, Paredes R, Pillay D, Shafer R, et al. 2011 update of the drug resistance mutations in hiv-1. Top Antivir Med. 2011; 19(4):156\u201364.","journal-title":"Top Antivir Med."},{"issue":"3","key":"452_CR27","doi-asserted-by":"publisher","first-page":"264","DOI":"10.1145\/331499.331504","volume":"31","author":"AK Jain","year":"1999","unstructured":"Jain AK, Murty NM, Flynn PJ. Data clustering: A review. ACM Comput Surveys. 1999; 31(3):264\u2013323.","journal-title":"ACM Comput Surveys"},{"issue":"1","key":"452_CR28","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1093\/jac\/dkt316","volume":"69","author":"GL Melikian","year":"2013","unstructured":"Melikian GL, Rhee S-Y, Varghese V, Porter D, White K, Taylor J, et al. Non-nucleoside reverse transcriptase inhibitor (nnrti) cross-resistance: implications for preclinical evaluation of novel nnrtis and clinical genotypic resistance testing. J Antimicrob Chemother. 2013; 69(1):12\u201320.","journal-title":"J Antimicrob Chemother."},{"issue":"1","key":"452_CR29","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1145\/1497577.1497578","volume":"3","author":"HP Kriegel","year":"2009","unstructured":"Kriegel HP, Kr\u00f6ger P, Zimek A. Clustering high-dimensional data: A survey on subspace clustering, pattern-based clustering, and correlation clustering. ACM Trans Knowl Discov Data. 2009; 3(1):1\u201358.","journal-title":"ACM Trans Knowl Discov Data"},{"key":"452_CR30","unstructured":"R Development Core Team. R: A language and environment for statistical computing. 2008. \n                    http:\/\/www.R-project.org\n                    \n                  . ISBN 3-900051-07-0."},{"key":"452_CR31","volume-title":"Proceedings of the 2008 Symposium on Applied Computting","author":"LV Ara\u00fajo","year":"2008","unstructured":"Ara\u00fajo LV, Calvez V, Ferreira JE. Hiv drug resistance analysis tool based on process algebra. In: Proceedings of the 2008 Symposium on Applied Computting. Ceara Brazil: Fortaleza: 2008. p. 1358\u201363."},{"key":"452_CR32","unstructured":"Maechler M, Rousseeuw P, Struyf A, Hubert M, Hornik K. Cluster: Cluster analysis basics and extensions. 2014. R package version 1.15.3 \u2014 For new features, see the \u2018Changelog\u2019 file (in the package source)."},{"issue":"8","key":"452_CR33","doi-asserted-by":"publisher","first-page":"651","DOI":"10.1016\/j.patrec.2009.09.011","volume":"31","author":"AK Jain","year":"2010","unstructured":"Jain AK. Data clustering: 50 years beyond k-means. Pattern Recognit Lett. 2010; 31(8):651\u201366.","journal-title":"Pattern Recognit Lett."},{"issue":"11","key":"452_CR34","doi-asserted-by":"publisher","first-page":"1961","DOI":"10.1086\/430002","volume":"191","author":"A Calazans","year":"2005","unstructured":"Calazans A, Brindeiro R, Brindeiro P, Verli H, Arruda M, Gonzalez L, et al. Low accumulation of l90m in protease from subtype f hiv-1 with resistance to protease inhibitors is caused by the l89m polymorphism. J Infectious Diseases. 2005; 191(11):1961\u201370.","journal-title":"J Infectious Diseases"},{"issue":"4","key":"452_CR35","doi-asserted-by":"publisher","first-page":"455","DOI":"10.1002\/prot.1057","volume":"43","author":"Mahalingam","year":"2001","unstructured":"Mahalingam, e.a. Bhuvaneshwari. Structural implications of drug resistant mutants of hiv 1 protease: High resolution crystal structures of the mutant protease substrate analogue complexes. Proteins: Structure Function Bioinf. 2001; 43(4):455\u201364.","journal-title":"Proteins: Structure Function Bioinf."},{"key":"452_CR36","doi-asserted-by":"publisher","first-page":"316","DOI":"10.1310\/67TE-GPXQ-R1LB-BPKG","volume":"3","author":"Clotet","year":"2002","unstructured":"Clotet, e.a. Bonaventura. Prevalence of hiv protease mutations on failure of nelfinavir-containing haart: a retrospective analysis of four clinical studies and two observational cohorts. HIV Clin trials. 2002; 3:316\u201323.","journal-title":"HIV Clin trials"},{"issue":"9639","key":"452_CR37","doi-asserted-by":"publisher","first-page":"646","DOI":"10.1016\/S0140-6736(08)61081-8","volume":"372","author":"J Molina","year":"2008","unstructured":"Molina J, Andrade-Villanueva J, Echevarria J, Chetchotisakd P, Corral J, David N, et al. Once-daily atazanavir\/ritonavir versus twice-daily lopinavir\/ritonavir, each in combination with tenofovir and emtricitabine, for management of antiretroviral-naive hiv-1-infected patients: 48 week efficacy and safety results of the castle study. Lancet. 2008; 372(9639):646\u201355.","journal-title":"Lancet"},{"issue":"11","key":"452_CR38","doi-asserted-by":"publisher","first-page":"1000225","DOI":"10.1371\/journal.pcbi.1000225","volume":"4","author":"Z Brumme","year":"2008","unstructured":"Brumme Z, John M, Carlson J, Brumme C, Chan D, Brockman M, et al. Phylogenetic dependency networks: Inferring patterns of ctl escape and codon covariation in hiv-1 gag. PLoS Comput Biol. 2008; 4(11):1000225.","journal-title":"PLoS Comput Biol."},{"issue":"8","key":"452_CR39","doi-asserted-by":"publisher","first-page":"6687","DOI":"10.1371\/journal.pone.0006687","volume":"4","author":"Z Brumme","year":"2009","unstructured":"Brumme Z, John M, Carlson J, Brumme C, Chan D, Brockman M, et al. Hla-associated immune escape pathways in hiv-1 subtype b gag, pol and nef proteins. PLoS ONE. 2009; 4(8):6687.","journal-title":"PLoS ONE"},{"issue":"5","key":"452_CR40","doi-asserted-by":"publisher","first-page":"363","DOI":"10.1191\/0962280204sm373ra","volume":"13","author":"VM Iven","year":"2004","unstructured":"Iven VM, Bock H-H, Boeck PD. Two-mode clustering methods: astructuredoverview. Stat Methods Med Res. 2004; 13(5):363\u201394.","journal-title":"Stat Methods Med Res."},{"key":"452_CR41","doi-asserted-by":"publisher","first-page":"737","DOI":"10.1093\/cid\/cis501","volume":"55","author":"JH Brehm","year":"2012","unstructured":"Brehm JH, Koontz DL, Wallis CL, Shutt KA, Sanne I, Wood R, et al. Frequent emergence of n348i in hiv-1 subtype c reverse transcriptase with failure of initial therapy reduces susceptibility to reverse-transcriptase inhibitors. Clin Infectious Diseases. 2012; 55:737\u201345.","journal-title":"Clin Infectious Diseases"}],"container-title":["BMC Bioinformatics"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s12859-015-0452-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12859-015-0452-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12859-015-0452-0","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12859-015-0452-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,2,17]],"date-time":"2020-02-17T13:39:45Z","timestamp":1581946785000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcbioinformatics.biomedcentral.com\/articles\/10.1186\/s12859-015-0452-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,2,5]]},"references-count":41,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2015,12]]}},"alternative-id":["452"],"URL":"https:\/\/doi.org\/10.1186\/s12859-015-0452-0","relation":{},"ISSN":["1471-2105"],"issn-type":[{"value":"1471-2105","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,2,5]]},"assertion":[{"value":"17 September 2013","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 January 2015","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 February 2015","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}],"article-number":"35"}}